MoonLake Immunotherapeutics (NASDAQ: MLTX)

📍 Zug, Switzerland🗓 Founded 2021👥 133 employees💰 Last funded Mar 2026
Biotechnology Research🌐 moonlaketx.com
Website LinkedIn
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in MoonLake Immunotherapeutics (NASDAQ: MLTX)?
MoonLake Immunotherapeutics (NASDAQ: MLTX) has 1 investors on record on gritt.io, 1 mid-stage.
When did MoonLake Immunotherapeutics (NASDAQ: MLTX) last raise funding?
The most recent investment in MoonLake Immunotherapeutics (NASDAQ: MLTX) recorded on gritt.io was in March 2026.
When was MoonLake Immunotherapeutics (NASDAQ: MLTX) founded?
MoonLake Immunotherapeutics (NASDAQ: MLTX) was founded in 2021.
What industry is MoonLake Immunotherapeutics (NASDAQ: MLTX) in?
MoonLake Immunotherapeutics (NASDAQ: MLTX) operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MoonLake Immunotherapeutics (NASDAQ: MLTX) based?
MoonLake Immunotherapeutics (NASDAQ: MLTX) is headquartered in Zug, Switzerland.